<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>162</id><no>I-SPY2-NCT01042379</no><status>Open</status><title>I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)&#xD;
</title><secondary_protocol_no>I SPY-2</secondary_protocol_no><nct_id>NCT01042379</nct_id><sponsor_type>Industrial; Institutional</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><scope>National</scope><disease_site>Breast</disease_site><PI>Isaacs, Claudine</PI><institution>Lombardi Comprehensive Cancer Center : Lana Kheir; Medstar Washington Hospital Center</institution><oncology_group>Breast<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group><item><contact_id>14763</contact_id><item_description>Lana Kheir</item_description><js_safe_str>Lana Kheir</js_safe_str><email>lk814@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>